Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1462 participants.

Also called NCT01268371

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,462 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01268371
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01268371. Randomized; single masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2015-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents
Acronym
BESS
Intervention (Device)
Promus Element, Boston Scientific Corporation
Intervention (Device)
Nobori, Terumo Corporation (Japan)
Lead sponsor
Ajou University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01268371
Content hash
034fc92e1371359d84aeee61c7799c50eaa05bcd7028f202fa2109c427d90a96